In vitro fluorescence studies of transcription factor IIB-DNA interaction by Górecki, Andrzej et al.
Regular paper
In vitro fluorescence studies of transcription factor IIB–DNA 
interaction*
Andrzej Górecki*, Małgorzata Figiel and Marta Dziedzicka-Wasylewska
Department of Physical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland
General transcription factor TFIIB is one of the basal con-
stituents of the preinitiation complex of eukaryotic RNA 
polymerase II, acting as a bridge between the preinitia-
tion complex and the polymerase, and binding promot-
er DNA in an asymmetric manner, thereby defining the 
direction of the transcription. Methods of fluorescence 
spectroscopy together with circular dichroism spectros-
copy were used to observe conformational changes in 
the structure of recombinant human TFIIB after binding 
to specific DNA sequence. To facilitate the exploration 
of the structural changes, several site-directed muta-
tions have been introduced altering the fluorescence 
properties of the protein. Our observations showed that 
binding of specific DNA sequences changed the protein 
structure and dynamics, and TFIIB may exist in two con-
formational states, which can be described by a different 
microenvironment of W52. Fluorescence studies using 
both intrinsic and exogenous fluorophores showed that 
these changes significantly depended on the recognition 
sequence and concerned various regions of the protein, 
including those interacting with other transcription fac-
tors and  RNA polymerase II. DNA binding can cause re-
arrangements in regions of proteins interacting with the 
polymerase in a manner dependent on the recognized 
sequences, and therefore, influence the gene expression.
Key words: transcription factors, TF2B, TFIIB, fluorescence spectros-
copy, fluorescence quenching, site directed mutagenesis
Received: 14 March, 2015; revised: 20 April, 2015; accepted: 20 May, 
2015; available on-line: 18 August, 2015
INTRODUCTION
General transcription factor IIB (TFIIB) is one of the 
basal constituents of the preinitiation complex of eukary-
otic RNA polymerase II, which synthesizes mRNAs and 
snRNAs. The role of the TFIIB protein is recognition 
of specific DNA sequences within the promoter region 
as well as recruitment and proper positioning of RNA 
polymerase II (RNAPII). As a monomeric protein re-
quiring no post-translational modifications, TFIIB can be 
expressed in a prokaryotic system in a fully functional 
form (Deng & Roberts, 2007). TFIIB molecule com-
prises two domains of different functions, yet affecting 
each other. The N-terminal domain (NTD) contains a 
β-sheet and a C3H type zinc finger (Chen et al., 2000) 
that binds to RNAPII near the active site (Kostrewa et 
al., 2009). The C-terminal domain (CTD) of TFIIB in-
teracts with promoter DNA, TATA-box binding protein 
(TBP) and numerous transcription activators (Deng & 
Roberts, 2007). The two DNA-binding motifs are imper-
fect direct repeats of cyclin-like structure (Bagby et al., 
1995; Malik et al., 1993), that specifically recognize two 
promoter fragments, located immediately upstream and 
downstream of the TATA box (Lagrange et al., 1998; 
Tsai & Sigler, 2000). The binding is direct (Lagrange et 
al., 1998) but simultaneous interaction at both sites is 
enabled only by previous binding of TBP that bends the 
DNA molecule about 80o (Lee & Hahn, 1995; Nikolov 
et al., 1995). 
TFIIB molecule can exist in several conformations. 
Firstly, the orientation of the two cyclin-like repeats is 
different for the free CTD NMR structure (Bagby et al., 
1995) and the X-ray structure of the CTD complexed 
with TBP and DNA (Nikolov et al., 1995). Moreover, 
the whole protein can adopt either closed or open 
form, due to an intra-molecular binding between NTD 
and CTD (Grossmann et al., 2001; Hayashi et al., 1998; 
Roberts & Green, 1994). The equilibrium between those 
conformations regulates TFIIB function within the 
preinitiation complex (Hawkes et al., 2000). The closed 
conformation has been shown to stabilize TFIIB binding 
to TBP and DNA in vitro (Bangur et al., 1999; Zhang et 
al., 2000), while the open conformation promotes tran-
scriptional activation (Hawkes et al., 2000) and is stabi-
lized by a number of transcription activators like acidic 
activator (Roberts & Green, 1994), VP16 10712906, Vpr 
(Agostini et al., 1999), and Pho4 (Wu & Hampsey, 1999). 
Although crucial for proper course of transcription, 
the TFIIB-DNA interaction is not yet thoroughly un-
derstood. Therefore we aimed to investigate what struc-
ture changes in TFIIB accompany DNA binding. Two 
sequences: adenovirus major late promoter (AdML) and 
adenovirus E4 promoter (AdE4), were chosen as exam-
ples for interaction studies. They differ in their agree-
ment with the consensus sequence (Deng & Roberts, 
2005; Lagrange et al., 1998), with AdML being closer to 
the consensus. Both sequences are commonly used for 
investigating transcription initiation in Eucaryota (Deng 
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& Roberts, 2005; Elsby et al., 2006; Tran & Gralla, 2008; 
Zheng et al., 2004).
MATERIALS AND METHODS
Materials. Agarose was purchased from ABO. IPTG 
was from Biosynth AG. Bromophenol blue, DTT, 
β-mercaptoethanol, Nonidet P-40, PMSF, TCEP, Zinc 
chloride were from Fluka. Bisacrylamide, Coomassie 
Brillant Blue, Ethidium bromide, Acrylamide, SDS were 
from ICN. Ammonium persulfate, Glycerol, Magnesium 
chloride, TEMED were from BioShop. Agar and Tris 
were from MP Biomedicals. Ethanol, Methanol, Or-
thophosphoric acid, Potassium chloride, Sodium chlo-
ride, Acetic acid were from POCh. Ampicillin was from 
Polfa Tarchomin. Calcium chloride, EDTA, Glycine, 
Hepes, Imidazole, PEG8000, Isopropanol were from 
Sigma-Aldrich. Yeast extract was from Invitrogen. Un-
stained Protein Ladder, GeneRuler™ 1 kb DNA Ladder, 
Pfu polymerase, dNTPs, restriction enzymes: NheI, Hin-
dIII, DpnI and proper reaction buffers were purchased 
from Fermentas. Ni-NTA His-Bind Resin was from No-
vagen. Clean-Up, Gel-Out and Plasmid Mini kits were 
from A&A Biotechnology. All measurements were per-
formed in buffers prepared in water purified with the 
Millipore system.
Plasmids. pIIB1 encoding open reading frame of hu-
man TFIIB – gift of I. Ha and D. Reinberg (Ha et al., 
1991); pET-21a (Novagen) — expression vector.
Primers. See Table 1.
Bacterial strains. E. coli DH5α (Invitrogen) – used in 
cloning and for plasmid amplification; E. coli BL21(DE3) 
(Invitrogen) – used for TFIIB expression.
Oligonucleotide duplexes containing the DNA se-







Cloning and site directed mutagenesis. The full-
length human TFIIB gene was amplified by polymerase 
chain reaction (PCR) from pIIB1 using Pfu polymerase 
(Fermentas). To create the TFIIB-His6 construct, TF2f 
and TF2r primers were used, and the gene was cloned 
into NheI and HindIII sites in the pET21a vector (No-
vagen) and sequenced. All cloning steps were performed 
using the E. coli DH5α (Novagen) strain. The cloning 
protocol included the proteinase K (Sigma-Aldrich, mo-
lecular biology grade) digestion step (Crowe et al., 1991). 
For carrying out modification of the TFIIB-His6 con-
struct, QuikChange (Stratagene) directed mutagenesis 
technique have been used in standard conditions. W52 
residue has been substituted by phenylalanine, tyros-
ine, valine or leucine, using TF2W52Ff & TF2W52Fr; 
TF2W52Yf & TF2W52Yr; TF2W52Vf & TF2W52Vr; 
TF2W52Lf & TF2W52Lr primers respectively. In case 
of substitution of cysteine residues: C181S, C194S or 
C223S, TF2C181Sf & TF2C181Sr; TF2C194Sf & TF-
2C194Sr; TF2C223Sf & TF2C223Sr; primers were used 
respectively. All cloning steps were performed using 
the E. coli DH5α (Novagen) strain. All the obtained 
constructs were sequenced and aligned with human 
TFIIB sequence from NCBI database (accession code: 
NM_001514). 
Protein expression and purification. For expression 
experiments, the plasmids were freshly transformed into 
the E. coli strain BL21(DE3) (Novagen) and were grown 
on the LB-agar plates with ampicillin (100 μg/mL) over-
night at 37°C. LB-ampicillin medium (2 mL) was inocu-
lated with a single colony from LB-ampicillin agar plate 
and grown for 8 h at 37°C, then this culture was used 
to inoculate 30 mL LB-ampicillin medium and grown at 
37°C. The overnight culture was added to 2 L of LB-
ampicillin and grown in Erlenmeyer flask in water bath 
with 150 RPM shaking at 37°C. Expression was induced 
at an O.D. 600 of 0.5–0.6 with 0.1 mM isopropyl β-d-1-
thiogalactopyranoside (IPTG) overnight at 18°C. At the 
time of induction, the cultures were supplemented with 
ZnCl2 to a concentration of 0.1 mM. Cells were harvest-
ed by centrifugation at 7000 × g for 15min at 4°C, pel-
leted and stored frozen at –20°C.
The bacterial pellet from the 2 L culture was resus-
pended in 30 mL of buffer A (Hepes 50 mM pH 7.5, 
NaCl 200 mM, glycerol 20%); buffer A contained also 
DNAse 100 U/mL, CaCl2 5 mM, MgCl2 2.5 mM and 
phenylmethylsulfonyl fluoride (PMSF) 1 mM. The sus-
pension was sonicated for six 30-s bursts on ice. The 
lysate was cleared by centrifugation (20 krcf (rela-
tive centrifugal force), 60 min, 4°C), and the superna-
tant was loaded onto a 5-mL nickel-nitrilotriacetic acid 
(Ni–NTA) gravity-flow column (Novagen), which was 
previously equilibrated in buffer A containing also CaCl2 
5 mM, MgCl2 2.5 mM, PMSF 1 mM and dithiothreitol 
(DTT) 1 mM. The column was washed with 15–20 col-
umn volumes (CV) of buffer A1 (Hepes 50 mM pH 7.5, 
NaCl 1 M, glicerol 20%, imidazole 20 mM and PMSF 
1 mM) with addition of DTT 1 mM. The protein was 
then eluted in buffer A with addition of 300 mM im-
Table 1. Sequences of primers used for cloning and site directed mutagenesis
Primer designation* forward primers reverse primers
TF2 CTAGCTAGCACCAGCCTGTTGG CCCAAGCT TTAGCTGTGGTAG
TF2W52F GGATCTGA ATTTCGAACTTTC GAAAGTT CG AAATTCAGATCC
TF2W52Y GGATCTGAATATCGAACTTTC GAAAGTTCG ATATTCAGATCC
TF2W52V GGAT CTGA AGTGCGAACTTTC GAAAGTTCG CACTTCAGATCC
TF2W52L GGATCTGAATTGCGAACTTTC GAAAGTTCG CAATTCAGATCC
TF2C181S CATT TAAA GAA ATATCTGCCGTATCACGAATTTC GAAATTCGT GATACGGCAGATATTTCTTTAAATG
TF2C194S GAAAGAAA TTGGTCGGTCTTTTAAACTTATTTTG CAAAATAA GTTTAAAAGACCGACCAATTTCTTTC
TF2C223S GGTTCTGTTCCAACCTTAGCCTTCC GGAAGGCT AAGGTTGGAACAGAACC
The sequences are given in order from 5’ to 3’; *For the primer names used in the text the letters „f” and „r” were added to denote the forward 
and reverse primers, respectively.
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idazole and 1mM DTT, 1.5 mL fractions were harvest-
ed. In case of samples prepared for fluorescent labeling, 
tris(2-carboxyethyl)phosphine (TCEP) substituted DTT 
in the last 2CV of A1 wash and in the elution buffer. 
The whole purification procedure was carried at 4°C to 
decrease protease activity, thereby reducing protein di-
gestion level. The protein concentration was determined 
in triplicates with the Bradford assay (Bradford, 1976), 
calibrated with bovine serum albumin (BSA) (Sigma-Al-
drich). The purification process was monitored by so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS/PAGE) (Laemmli, 1970) in 12% gel. Fractions 
containing TFIIB or its variants were pooled and sub-
jected to three-step dialysis at 4°C against buffer A with 
addition of DTT 5 mM (1:100 ratio) or buffer B (Hepes 
50 mM pH 7.9, NaCl 100 mM, glycerol 10%, DTT 2 
mM) and frozen at –80°C.
Fluorescence labeling. In order to covalently label 
the sulfhydryl groups of TFIIB or its variants, 2-(4’-ma-
leimidylanilino)naphthalene-6-sulfonic acid (MIANS) 
(Molecular probes) was used. The dye stock solution was 
prepared in concentration of 20 mM in 100% dimethyl 
sulfoxide (DMSO), and kept in darkness to protect the 
dye molecules from light. The protein was subjected to 
labeling directly after the purification procedure - before 
final dialysis. The Dye reagent was added in molar excess 
(2:1; 4:1; 6:1; 8:1; 9:1; 11:1), taking care not to exceed 
1% DMSO concentration. The mixtures were incubated 
for 30 minutes at room temperature in darkness, then 
DTT was added to a concentration of 1 mM. The un-
bound fluorescent dye reacted with DTT and was then 
removed by the dialysis described above. After the third 
dialysis step, the protein labeling degree was calculated 
as the ratio of the absorption-determined concentration 
of the fluorescent probe, and the concentration of the 
protein determined by the Bradford method. The extinc-
tion coefficient used to calculate the concentration of 
MIANS according to the Beer-Lambert law was 27 000 
M–1cm–1 at 322 nm.
Spectroscopic studies. Circular dichroism measure-
ments were conducted using a J-710 spectropolarimeter 
(Jasco) equipped with an F25 temperature control unit 
(Julabo) in quarts cuvettes of 0.2 mm path-length (Hell-
ma). The spectra were collected in the range of 190–250 
nm with 1 nm data pitch, 10 nm/min scanning speed, 
8 s integrating time, and 2 nm bandwidth and averaged 
over three acquisitions.. All spectra were corrected for 
the effect from the buffer and all measurements were 
converted to molar residual ellipticity units as described 
elsewhere. The protein concentration were 20 µM. 
Fluorescence emission spectra were recorded in buffer 
A using spectrofluorimeter Fluorolog-3 equipped with 
an F25 temperature control unit (Julabo). Spectra were 
measured in thermostated cuvette 3 × 3 mm (Hellma) at 
25°C. Spectra were obtained with a 1 nm data pitch, in-
tegration time 0.2 s for every wavelength and averaged 
over three acquisitions. In case of the dye fluorescence 
measurements excitation wavelength was 320 nm and 
range of emission spectrum was 350–500 nm. Slit widths 
on excitation and emission monochromators were set at 
3  and 2 nm respectively, for TFIIB wt, TFIIB C194S 
and TFIIB C194S C223S, or 3 and 3 nm, respectively 
for C181S or 4 and 3 nm respectively for C223S mu-
tants. In every case, buffer A spectrum was first mea-
sured and then subtracted from sample  measurement 
spectrum. The protein concentration was 1 µM, while 
ds DNA (AdML or AdE4) concentration was 0.5, 1, 1.5 
and 2 µM (if present).
The steady-state fluorescence quenching experiments of 
TFIIB intrinsic fluorescence (tryptophan residue W52) were 
performed at 25°C in buffer B in a Fluorolog-3 equipped 
with an F25 temperature control unit (Julabo). The spectra 
were measured in thermostated quartz cuvette 10 × 4 mm 
(Hellma) at 25°C. The corrected spectra were recorded in 
the range from 305 to 450 nm, with 0.5 nm data pitch, in-
tegration time 0.1 s for every wavelength and averaged over 
three acquisitions. The excitation wavelength was 295 nm. 
The excitation and emission slits were set at 5 and 5 nm, 
respectively. Four molar (4 M) KI solution used as a flu-
orescence quencher contained 0.1 M sodium thiosulfate to 
inhibit the formation of I3–. Fluorescence intensities were 
corrected for any dilution effects as well as for residual 
buffer emission and Raman scattering. The quenching data 
were analyzed using the Stern–Volmer equation:
where F0 and F are fluorescence intensities in the ab-
sence and presence of quencher, Q, respectively, Ki is 
the dynamic quenching constant and fi is the fractional 
contribution of component i. The quenching rate con-
stant kq was calculated as kq= Ki/<τ>, where <τ> is the 
mean fluorescence lifetime in the absence of the quench-
er. The Stern–Volmer equation was fitted to the experi-
mental data by an iterative nonlinear least square method 
using Origin 9.1 software. The data were analyzed using 
one-way analysis of variance (ANOVA) test (GraphPad 
Prism 5.0, USA) with the t-test to compare the statistical 
significance between groups. A p-value of less than 0.05 
indicated statistically significant results.
Time-correlated single photon counting (TCSPC) mea-
surements were performed on a FluoroCube fluorimeter 
(Horiba, France). Tryptophan residue was excited with 
pulsed NanoLED diodes at 294 nm (pulse duration of 
700 ps) operated with 1 MHz repetition. Maximum num-
ber of photons to be counted was set to 10 000 and in a 
200 ns range. To avoid pulse pile-up, the power of the 
pulses was adjusted to an appropriate level using a neu-
tral gradient filter. The fluorescence emission was record-
ed using a picosecond detector TBX04 (IBH, JobinYvon, 
UK) data station and the DAS 6 (JobinYvon (IBH, UK)) 
software was used for data acquisition and signal analysis. 
All the fluorescence decays were measured in a 10 × 10 
mm quartz cuvette, using emitter cut-off filter with trans-
mittance >320 nm (320FG01 glass filter from and An-
dover corp.) The excitation profiles, required for the de-
convolution analysis, were measured without the emitter 
filters on a light scattering cuvette. All measurements were 
performed at 25°C. Each fluorescence decay was analyzed 
with a multi-exponential model given by the equation: 
where αi and τi are the pre-exponential factor and decay 
time of component i, respectively. Best fit parameters 
were obtained by minimization of reduced χ2 value as 
well as residual distribution of the experimental data. 
The mean lifetime of fluorescence decay was calculated 
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RESULTS
Protein expression and purification
Recombinant human TFIIB was produced in pET 
expression system with His6-tag at its C-terminus and 
constituted the majority of the total protein pool (Fig. 1, 
lanes I, L). SDS/PAGE analysis also showed that the 
amount of TFIIB in soluble and insoluble fractions (de-
noted as S and P in the Fig. 1) are comparable. The 
protein was purified from the soluble fraction to high 
homogeneity, above 95%, with use of metal affinity 
chromatography (Fig. 1, lanes 1–7). The purity was ad-
equate for structural studies. Similar condition for TFIIB 
expression and purification has been reported previously 
(Thompson et al., 2009; Thomsen et al., 2001).
Intrinsic fluorescence studies
TFIIB exhibited intrinsic fluorescence due to its single 
tryptophan residue, located in the hinge region that con-
nects NTD and CTD. TFIIB fluorescence emission was 
susceptible to quenching with iodide.Typical Stern–Vol-
mer plots in the absence and in the presence of specific 
DNA are presented in Fig. 2. 
In each case the Stern–Volmer plots curved down 
and could not be satisfactorily fitted to a single-compo-
nent model, i.e. to Eqn. (1) with n = 1. Addition of a 
second component significantly improved the fit, while 
addition of a third component did not improve  it fur-
ther. In case of the apo protein, the obtained reduced 
χ2 values were: 1.02×10–3, 3.00×10–5 and 3.40×10–5 for 
the single-, double- and triple-component analysis, for 
AdML-ligated TFIIB these values equaled: 9.04×10–4, 
3.38×10–5, 2.19×10–5 and for AdE4 ligated protein — 
1.13×10–4, 6.01×10–5 and 6.87×10–5. The χ2 values in-
dicated that in each case the triple-component analysis 
was not significantly better than the double-component 
analysis. Also, in any case the distribution of the resid-
uals was not improved upon the addition of the third 
exponent (Fig. 2B). Therefore the fluorescence quench-
ing can be described by a two-component model, in 
which one fluorophore class is less accessible for the 
quencher and characterized by K1 = 1.83 ± 0.14 M–1 
for the apo protein, while the other is more accessible 
for iodide with K2 = 16.19 ± 2.77 M–1. The presence 
of the specific DNA sequence changed the value of 
the first component slightly if any, to 1.83 ± 0.11 M–1 
and 1.12 ± 0.19 M–1 for AdML and AdE4, respectively. 
The value of the quenching constant for the second 
component varied more significantly in the presence of 
a specific DNA and was equal to 21.03 ± 4.56 M–1 and 
9.69 ± 1.98 M–1 for AdML and AdE4, respectively. 
To further analyze the quenching parameters, time-
resolved measurements were performed. Figure 3 shows 
an exemplary TFIIB intrinsic fluorescence decay. 
The best fit was obtained for triple exponential de-
cay, giving decay times of 0.50 ± 0.05 ns, 2.86 ± 0.07 
ns, 6.53 ± 0.09 ns, with respective contributions: 0.11 
± 0.01, 0.55 ± 0.01, 0.34 ± 0.01. The mean fluores-
cence lifetime, calculated from equation 3, was 3.85 ± 
Figure 1. SDS/PAGE analysis of TFIIB purification process.
0 — bacterial culture prior to induction; I — bacterial culture after 
the induction; L — bacterial cell lysate; S — supernatant obtained 
after centrifugation; P — pellet; FT — NiNTA flowthrough; W — 
NiNTA wash (20 mM imidazole); M — molecular mass marker; 1–7 
— fractions eluted from NiNTA with 300 mM imidazole. The num-
bers on the marker lane indicate protein molecular mass in kD. 
Figure 2. Quenching of TFIIB intrinsic fluorescence by iodide.
(Panel A) Stern-Volmer plot for TFIIB alone (squares), and in the 
presence of AdML (circles) and AdE4 (triangles). Continuous lines 
represent the best fits to the experimental data. Insert: a repre-
sentative set of TFIIB emission spectra in the absence of DNA ob-
tained for KI concentrations: 0.00 M; 0.01 M; 0.03 M; 0.05 M; 0.08 
M; 0.11 M; 0.18 M; and 0.23 M. (Panel B) Residual distribution in 
term of one-component (black) two-component (gray) and three-
component (open) analysis of Stern-Volmer equation.
Figure 3. Fluorescence lifetime of TFIIB. 
(Upper panel) Open circles show the decay of W52 fluorescence 
emission (Decay), while solid lines are a triple exponential fit. The 
excitation pulse profile, set up at 294 nm is show by the squares 
curve (Prompt). (Bottom panel) residual distribution for the fitting 
of three exponents. 
Vol. 62       417Fluorescence studies of TFIIB–DNA interaction
0.02 ns and is typical for tryptophan residues. Quench-
ing rate constants were calculated from the obtained 
values and presented in Table 2 with the fractions of 
the individual components. One-way ANOVA showed 
statistical differences for f1 [F(2.8)=8.797; P<0.05]; 
kq1 [F(2.8)= 21.66; P<0.01]; and kq2 [F(2.8)= 9.344; 
P<0.05]. T-test was used to compare statistical differ-
ence between the groups. 
Statistical analysis showed that the parameters kq1 
and kq2 changed in a statistically significant way only for 
TFIIB bound to AdE4 sequence. The analysis showed 
also a statistically significant change in the parameter f1, 
although it concerned only the case when TFIIB was as-
sociated with AdML sequence.  Thus, all three param-
eters are different for TFIIB after binding to AdML and 
AdE4 promoters.
Changing the fluorescent properties of TFIIB
In order to modify the fluorescent properties of 
TFIIB, W52 was replaced with other residues: pheny-
lalanine, tyrosine, leucine, or valine, using site directed 
mutagenesis. Despite obtaining the correct genetic 
constructs, very low level of protein expression pre-
cluded their purification in the case of substitutions 
with leucine and valine (data not shown). Introduction 
of aromatic residues in place of W52 did not cause 
any significant decrease in the level of expression, 
although the circular dichroism spectra of these pro-
teins (Fig. 4) showed that the secondary structure has 
been changed.
The result presented above proves the high evolution-
ary conservation of W52 residue. As we were unable to 
substitute it without interfering with the protein struc-
ture, we decided to modify the fluorescent properties 
of TFIIB by fluorescent labeling. A solvatochromic dye, 
MIANS, was used, which covalently binds to sulfhydryl 
groups. Due to the presence of three water-accessible 
cysteine residues within the cyclin-like repeats of CTD, 
a series of TFIIB variants was designed to make the la-
beling more specific. None of these residues is evolu-
tionarily conserved, as can be judged by the alignment of 
TFIIB homolog sequences presented in the bottom part 
of Fig. 5. Therefore each of them was substituted, i.e., 
C181S, C194S, C232S, and additionally a double mutant 
C194S C232S was prepared. None of the mutations al-
tered the protein secondary structure (Fig. 6). 
Extrinsic fluorescence studies
MIANS emission intensity depends on the polar-
ity of its microenvironment. The emission spectra col-
Table 2. Fluorescence quenching parameters for TFIIB and its 
DNA complexes.
species f1 kq1 (109 M–1s–1) kq2 (109 M–1s–1)
TFIIB 0.69±0.04 0.48±0.04 4.2±0.7
TFIIB + AdML 0.78±0.03a 0.48±0.03 5.5±1.2
TFIIB + AdE4 0.61±0.07b 0.29±0.05aa, bb 2.5±0.5a, b
The statistical significance was evaluated using one-way ANOVA, fol-
lowed by T-test comparisons. The following symbols were used: 
aP<0.05; aa P<0.01 for the comparison of apo TFIIB with TFIIB ligated 
with DNA, bP<0.05; bbP<0.01 for the comparison of TFIIB ligated with 
AdML vs ligated with AdE4. 
Figure 4. Circular dichroism spectra of TFIIB mutants with sub-
stitutions of W52 residue. 
Solid line — wild-type TFIIB; squares — TFIIB W52F; circles — TFI-
IB W52Y. The obtained results indicate significant structural impor-
tance of W52 residue. An alignment of amino acid sequence of 
several TFIIB homologs was conducted using Clustal Omega pro-
gram (Sievers et al., 2011). Fragments of the alignment are shown 
in the upper part of Fig. 5.
Figure 5. Alignment of fragments of TFIIB sequence for homologs from: Homo sapiens, Rattus norvegicus, Xenopus leavis, Drosophila 
melanogaster, Saccharomyces cerevisiae, Pyrococcus furiosus, and Sulfolobus shibatae. 
The last digit of the number in the first line indicates the number of amino acid residue in the human TFIIB. Bold letters indicate amino 
acid residues modified in the present study and the corresponding amino acid residues in the homologs. Stars indicate residues that are 
conserved among all the species, colon — in most of the species, dot — similar residues. Data was obtained using Clustal Omega pro-
gram (Sievers et al., 2011).
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lected for MIANS-labeled proteins changed in the pres-
ence of AdML and AdE4, and the course of the above-
mentioned changes adopted a shape of a binding curve 
(Fig. 8). In case of the wild-type TFIIB, binding to DNA 
decreased MIANS fluorescence intensity only slightly, 
more significantly for AdE4. For the other protein vari-
ants, the changes were more profound. For C181S mu-
tant, the observed increase in fluorescence intensity was 
independent of the recognized sequence, while for the 
C194S mutant a change was seen only upon binding to 
AdE4.  Lack of C232 residue increased MIANS fluores-
cence intensity. The presence of DNA resulted in an in-
crease in fluorescence intensity, higher for AdML than 
for AdE4. On the other hand, substitution of C194 resi-
due resulted in a decrease in MIANS fluorescence inten-
sity, which was in turn greater for AdE4 sequence. The 
maximum changes in fluorescence intensity for each case 
are presented in Table 3. T-test was used to compare the 
statistical difference between the groups. 
DISCUSSION
Transcription factor IIB belongs to the family of gen-
eral transcription factors and plays a crucial role in RNA 
polymerase II preinitiation complex assembly. Its exist-
ence as a monomer in solution, and lack of post-trans-
lational modifications necessary for its activity, makes 
TFIIB the only general transcription factor that may be 
obtained in the fully functional form in a prokaryotic 
expression system (Deng & Roberts, 2007). These fea-
tures make TFIIB especially attractive for studying the 
influence of other macromolecules on the protein struc-
ture and its dynamics, especially using fluorescence tech-
niques. 
Tryptophan fluorescence has been widely used as a 
sensitive probe for studying conformational changes in 
protein structure (Lakowicz, 2006). TFIIB exhibits in-
trinsic fluorescence due to W52 residue, located in the 
hinge region that connects NTD and CTD (Bangur et 
al., 1999). Both, the presence of the only one tryptophan 
residue and its location allowed us to monitor possible 
changes in TFIIB structure without any additional modi-
fication of the protein. The presence of iodide in the so-
lution decreased the intrinsic fluorescence intensity, due 
to effective collisional quenching of tryptophan fluores-
cence by the ion. The effectiveness of the quenching is 
determined in general by the extent of tryptophan expo-
sure to the solvent, and typically for a single fluorophore 
it is described by linear relationship on the Stern-Volmer 
plot. Nevertheless, the graph we obtained was not lin-
ear but curved down, as can be seen in the Figure 2. 
The phenomenon can be best described by a two-com-
ponent model, with two fluorophore species differing 
in their availability for the quencher. For a single-tryp-
tophan protein, this justifies the existence of two forms 
of the protein. This can be interpreted as occurrence of 
two conformations of TFIIB, as we verified the protein 
sample to be highly pure, stable and homogeneous by 
size-exclusion chromatography and thermal denaturation 
analysis (results not shown). The obtained result is con-
sistent with the previously observed interaction between 
NTD and CTD, leading to coexistence of “open” and 
“closed” conformations of the protein in equilibrium 
(Elsby & Roberts, 2004; Reese, 2003). The assumption 
that reported in the literature conformational states are 
identical to the conformational states observed in this 
study appears to be reasonable and allows to conclude 
that the quenching results indicate that these conforma-
tions differ significantly in W52 exposure to the solvent 
and remain in thermodynamic equilibrium. 
The presence of DNA changed the quenching param-
eters, as can be seen in the Stern-Volmer plot (Figure 2). 
Moreover, AdML and AdE4 differently influenced the 
quenching efficiency. Thus the protein structure changed 
Figure 6. Circular dichroism spectra of TFIIB mutants with sub-
stitutions of cysteine residues. 
Solid line — wild-type TFIIB; circles — TFIIB C194S; triangles 
— TFIIB C233S; squares — TFIIB C181S; rhombs — TFIIB C194S 
C233S. Labeling with MIANS was performed for the wild-type pro-
tein and the cysteine-depleted  mutants, using several amounts of 
the dye (Fig. 7). 
Figure 7. Degree of MIANS labeling (a label:protein ratio) for dif-
ferent TFIIB mutants, depending on the initial dye-protein stoi-
chiometry. 
Table 3. Relative fluorescence intensity change induced by the 
presence of DNA
species AdML AdE4
TFIIB wt –6%±1% –12%±1%aa
TFIIB C181S 17%±4% 19%±1%
TFIIB C194S 3%±1% 26%±4%aaa
TFIIB C223S 88%±10% 63%±4%a
TFIIB C194S C223S –34%±4% –54%±5%aa
The statistical significance was evaluated using T-test for the com-
parison between AdE4 and AdML. The following symbols were used: 
aP<0.05; aaP<0.01; aaaP<0.001. 
Vol. 62       419Fluorescence studies of TFIIB–DNA interaction
upon binding to DNA in a sequence-specific manner. 
The average fluorescence lifetime in the absence of the 
quencher served to calculate the bimolecular quench-
ing rate constants shown in Table 2. In each case two 
fluorophore classes were observed, significantly differing 
in their accessibility to the quencher. The value of kq1 
indicates some level of fluorophore shielding, while kq2 
value is close to the diffusion-controlled limit (Lakowicz, 
2006). It is interesting that binding of AdML to TFIIB 
does not change any of the quenching rates characteris-
tic for the two states, but only the equilibrium between 
the “open” and “closed” form. Therefore the presence 
of the DNA does not change the vicinity of W52 in 
these forms. Binding of AdML increases the value of the 
f1 parameter, indicating greater dominance of the con-
formation with shielded tryptophan residue. In contrast, 
binding of AdE4 does not affect significantly the equi-
librium between the two forms, but substantially shields 
the tryptophan residue in both of them. It means that 
W52 is more buried, or electrostatic repulsion renders 
the fluorophore less accessible to the quencher. 
W52 is located in an important fragment of TFIIB 
that penetrates RNAPII during the  formation of the 
preinitiation complex. The obtained results indicate that 
the microenvironment of the residue depends on the 
recognized promoter, and so is the interaction inter-
face with RNAPII. It seems that TFIIB has the ability 
to “read” the sequence and affect the RNAP in a se-
quence-dependent manner.. It seems reasonable to draw 
the conclusion that in the transcription initiation process 
controlled by TFIIB, the DNA sequence is also impor-
tant, apart from the equilibrium constants for interac-
tions of the various transcription factors and DNA.
During the transcription activation, the transcription 
factors interact not only with RNAP, but also with each 
other, and therefore we decided to monitor other con-
Figure 8. Emission spectra of MIANS for labeled TFIIB variants: 
(A) wild-type; (B) C181S; (C) C194S; (D) C223S; (E) C194S C223S. 
Lines represent the spectra obtained for the respective protein 
alone (solid lines), and in the presence of AdML (dashed lines) and 
AdE4 (dotted lines). The inserts show relative fluorescence inten-
sity depending on the concentration of AdML (squares) or AdE4 
(triangles). 
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formational changes occurring in TFIIB. Since these in-
teractions include also regions within CTD (i.e. interact-
ing with VP16) we intended to relocate there the trypto-
phan residue as a fluorescent probe. This two-step pro-
cess involved replacing W52 with a similar residue and 
introducing a tryptophan residue in the desired location. 
Most frequently, tryptophan residues are replaced by 
other aromatic or hydrophobic amino acid residues. W52 
substitution with other aromatic residues influenced the 
protein secondary structure content (Fig. 4), while substi-
tution with hydrophobic residues prevented the efficient 
expression. W52 is located within the most conserved 
region of TFIIB and is unchanged among eucaryal and 
archeal homologs (Fig. 5). The important functional role 
of W52 is also indicated by W52A substitution, which 
decreased TFIIB affinity to the viral protein Vpr (Ago-
stini et al., 1999). Since it was impossible to relocate the 
tryptophan residue without disrupting the protein struc-
ture, we can assume that this residue plays not only a 
functional, but also a structural role, although it is lo-
cated in the hinge region. 
Due to the above-mentioned conclusions, the only 
possibility to monitor CTD structural changes with 
fluorescence measurements was to introduce an exog-
enous fluorophore, MIANS, that binds to sulfhydryl 
groups.Human TFIIB contains nine Cys residues, three 
of which form the zinc finger and are therefore inac-
cesible to chemical modification. Out of the remaining 
six cysteines, three are solvent-exposed: C181, C194, 
and C223 (Bagby et al., 1995) and therefore might be 
prone to labeling. All the three residues belong to the 
DNA-binding motifs but do not contact DNA direct-
ly (Nikolov et al., 1995). We substituted each of those 
cysteines with serine to make the labeling more specific, 
and to verify if they react with MIANS in the wild-type 
protein. The selected residues are not evolutionarily con-
served (Fig. 5), so their substitution may have not af-
fected the protein structure. The actual lack of structural 
significance of these residues was confirmed by circular 
dichroism spectroscopy (Fig. 6). 
The obtained degree of labeling was higher for the 
wild-type TFIIB and lower for the mutants, confirming 
the initial assumptions concerning the reactivity of the 
particular cysteine residues. The degree of labeling corre-
lated with the amount of dye added, but did not exceed 
1.0 in any case. Both C194 and C223 seem to react with 
the dye, since C194S C223S mutant was modified to a 
lesser degree than both C194S and C223S. Labeling of 
C181S mutant was similarly effective compared to the 
wild-type protein. This suggests that C181 residue does 
not bind MIANS in the wild-type protein, although it 
might do so in the mutants bearing substitutions of the 
more reactive cysteine residues (e.g. C194S C223S). Thus 
the labeling was semi-specific and at least some of the 
dye was placed within the DNA-binding motifs. 
The use of a solvatochromic fluorophore allowed to 
monitor structural changes induced by DNA binding in 
the vicinity of the dye. The emission spectra collected 
for MIANS-labeled proteins changed in the presence of 
DNA. The most profound changes were observed for 
the mutants lacking C223 (Fig. 8): twofold increase in 
MIANS fluorescence intensity was observed for TFIIB 
C223S and twofold decrease for TFIIB C194S C223S 
(Table 3). The observed signal changes significantly be-
tween the two promoter sequences and the difference 
was found statistically significant for all the protein vari-
ants except C181S. This could be explained by a differ-
ent impact of AdML and AdE4 on the microenviron-
ment of MIANS molecule bound to C181, localized 
within the BREd-binding domain while C194 and C223 
contact BREu more closely. Since the observed changes 
varied significantly between the two promoter sequences, 
they cannot be attributed simply to the more hydropho-
bic milieu of the DNA major groove, but rather they 
manifest an alteration of the protein conformation that 
depends on the promoter sequence. 
Interestingly, a stronger effect on the fluorescence 
intensity was observed for binding to AdE4 than to 
AdML — contrary to what could be expected from the 
fact that AdML is closer to the consensus sequence. A 
similar result was obtained by Zheng et al. in studies em-
ploying FRET between two fluorescent proteins fused to 
the ends of TFIIB molecule (Zheng et al., 2004). Dif-
ferent TFIIB epitopes are exposed during binding to 
AdML and to AdE4 (Fairley et al., 2002). AdE4 was 
also shown to be more sensitive than AdML to TFIIB 
mutation (Hawkes & Roberts, 1999).  Possibly, this dif-
ference might be caused by an interplay between BREu 
and BREd binding by TFIIB. Thus the observed differ-
ences probably reflect sequence-specific TFIIB action 
rather than simple difference in its affinity for the two 
sequences.  
Our findings, which are consistent with the results ob-
tained for prokaryotic transcription factor cAMP recep-
tor protein (Fic et al., 2007), may lead to a more general 
conclusion. In the transcription initiation process, subtle 
changes in the structure and dynamics of the various 
transcription factors, depending on reciprocal interac-
tions, play an important role, apart from the obvious 
structural aspects of the interaction between transcrip-
tion factors and the RNAP, leading to suitable geometry 
of the complex formation, mutual affinity of the indi-
vidual components or the kinetics of their interactions. 
These small changes can lead to significant synergies in 
the binding of these factors. Although this work is not 
an evident proof of the existence of such a process, it 
strongly suggests the possibility and the universality of 
its occurrence.
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